Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, Llc

Tbilisi 144

2 studies enrolling now · 8 studies all time

What they study most

Bladder Cancer, CRC (Colorectal Cancer), Dermatitis, Atopic, Idiopathic Pulmonary Fibrosis, MF, Moderate to Severe Plaque Psoriasis, Myelofibrosis, Non-small Cell Lung Cancer, Post-ET Myelofibrosis, Post-PV MF, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer — Recruiting now
• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis — Running, not enrolling
• To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis — Completed
• A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer — Running, not enrolling
• To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis — Completed
• LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) — Running, not enrolling
• Tomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART) — Status unconfirmed